X4 Pharmaceuticals Investor Relations Material
Latest events
Q1 2025
X4 Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from X4 Pharmaceuticals Inc
Access all reports
X4 Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for rare diseases, particularly those involving immune system dysfunctions. The company leverages its expertise in small-molecule therapeutics to address conditions associated with abnormal white blood cell activity. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for X4 Pharmaceuticals Inc
Q1 2025
X4 Pharmaceuticals Inc
Q3 2024
X4 Pharmaceuticals Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
XFOR
Country
🇺🇸 United States